Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

U.K. Devotes £60 Million for Science Entrepreneurship

The Engineering and Physical Sciences Research Council or EPSRC in the U.K. is funding 31 projects at British universities to encourage scientists to become new or better entrepreneurs. The £60 million ($US 95.3 million) program was announced today by Vince Cable, U.K.’s Secretary of State for Business, Innovation and Skills.

Under the program, EPSRC is . . . → Read More: U.K. Devotes £60 Million for Science Entrepreneurship

Swine Genome Offers Insights for Agriculture, Medicine

(Keith Weller, Agricultural Research Service/USDA)

An analysis of the pig genome by an international consortium highlights genetic mechanisms that can improve breeding practices and show similarities with humans for development of drugs. The findings by the International Swine Genome Sequence Consortium appear online in the journals Nature and Proceedings of the National Academy . . . → Read More: Swine Genome Offers Insights for Agriculture, Medicine

Wear-Resistant Diamond Tip Created for Nano-Manufacturing

William King (University of Illinois)

Engineers at University of Illinois, University of Pennsylvania, and Advanced Diamond Technologies Inc. in Romeoville, Illinois, developed a diamond tip for nanoscale lithography better able to meet heat and wear demands of semiconductor manufacturing. The team led by Illinois engineering professor William King (pictured left) published its findings . . . → Read More: Wear-Resistant Diamond Tip Created for Nano-Manufacturing

Nanotech Strategy Developed for Solid Tumor Drug Delivery

Manfred Ogris (Ludwig-Maximilians University)

Researchers at Ludwig-Maximilians University in Munich, with colleagues from Munich Technical University and Helmholtz Center Munich, engineered a gene that can generate anti-cancer agents deep inside solid cancerous tumors. The team led by Ludwig-Maximilians pharmacologist Manfred Ogris reported its findings online yesterday in the journal Molecular Therapy (paid subscription . . . → Read More: Nanotech Strategy Developed for Solid Tumor Drug Delivery

Method Devised to Improve Wireless Network Efficiency

Yingbo Hua, left, and Ping Liang (Peter Phun, University of California-Riverside)

Engineers at University of California in Riverside developed a method they say can double the efficiency of mobile wireless networks. Riverside electrical engineering professors Yingbo Hua and Ping Liang, with three graduate students, published their findings in a recent online issue of . . . → Read More: Method Devised to Improve Wireless Network Efficiency

Rice, Baylor to Study Hydrogel, Stem Cell Scaffolding

Rice University/Baylor University research team. L-R: Vivek Kumar, Rena D’Souza, Jeffrey Hartgerink, and Marci Kang. (Jeff Fitlow/Rice University)

Researchers at Rice University in Houston and Baylor College of Dentistry in Dallas received a National Institutes of Health grant to develop an injectable hydrogel that forms an active biological scaffold for tissue repair in . . . → Read More: Rice, Baylor to Study Hydrogel, Stem Cell Scaffolding

Cancer Diagnostics Biotech Lands $13 Million Series B Funds

(National Institutes of Health)

Epic Sciences Inc., a biotechnology diagnostics developer in San Diego, secured $13 million in series B financing, the second round of venture funding after initial start-up. The funding round includes new investors Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, as well as undisclosed individual participants.

Epic Sciences . . . → Read More: Cancer Diagnostics Biotech Lands $13 Million Series B Funds

Genomics Institute to Back Umbilical Cord Stem Cell Company

(Genome.gov)

Ontario Genomics Institute in Toronto, Canada is investing in Tissue Regeneration Therapeutics, also in Toronto, a company developing a technology for medical treatments with stems cells extracted from umbilical cords. Financial aspects of the investment were not disclosed.

The technology developed by Tissue Regeneration Therapeutics uses human umbilical cord perivascular cells or . . . → Read More: Genomics Institute to Back Umbilical Cord Stem Cell Company

VC, University Partner on Medical Device Start-Up Company

(Yale School of Medicine/Wikimedia Commons)

George Washington University in Washington, D.C., and venture capital company Allied Minds Inc. in Boston, formed LuxCath LLC, a new company that makes a device for increasing the speed and safety of surgery for irregular heartbeat. LuxCath’s technology is based on research by faculty at George Washington’s medical . . . → Read More: VC, University Partner on Medical Device Start-Up Company

Universities, Biotechs to Research Epilepsy Treatments

(National Institute of Mental Health)

A consortium of universities and biotechnology companies in Europe are developing a new strategy for treating epilepsy, a neurological disease affecting 50 million people worldwide. The group called EPIXCHANGE includes researchers from Lund University in Sweden, University of Ferrara in Italy, and the biotech companies Bioviron in France . . . → Read More: Universities, Biotechs to Research Epilepsy Treatments